Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes
about
Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activationElevated O-GlcNAc-dependent signaling through inducible mOGT expression selectively triggers apoptosisO-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1Hexosamines, insulin resistance, and the complications of diabetes: current status.Adipocyte extracellular matrix composition, dynamics and role in obesityRegulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytesCaenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauerO-GlcNAcylation: a bridge between glucose and cell differentiationFunctional O-GlcNAc modifications: implications in molecular regulation and pathophysiologyO-GlcNAcylation and Metabolic Reprograming in CancerPosttranslational regulation of Akt in human cancerLoss of C. elegans GON-1, an ADAMTS9 Homolog, Decreases Secretion Resulting in Altered Lifespan and Dauer FormationStructure of an O-GlcNAc transferase homolog provides insight into intracellular glycosylationElevation of Global O-GlcNAc Levels in 3T3-L1 Adipocytes by Selective Inhibition of O-GlcNAcase Does Not Induce Insulin ResistanceInhibition of a bacterial O-GlcNAcase homologue by lactone and lactam derivatives: structural, kinetic and thermodynamic analysesInhibition of O-GlcNAcase Using a Potent and Cell-Permeable Inhibitor Does Not Induce Insulin Resistance in 3T3-L1 AdipocytesCell-Penetrant, Nanomolar O-GlcNAcase Inhibitors Selective against Lysosomal HexosaminidasesSynergy of Peptide and Sugar in O-GlcNAcase Substrate RecognitionGaining insight into the inhibition of glycoside hydrolase family 20 exo-β-N-acetylhexosaminidases using a structural approachThe hexosamine signaling pathway: deciphering the "O-GlcNAc code"Structure and mechanism of a bacterial beta-glucosaminidase having O-GlcNAcase activityIncreasing brain protein O-GlcNAc-ylation mitigates breathing defects and mortality of Tau.P301L miceInsulin dynamically regulates calmodulin gene expression by sequential o-glycosylation and phosphorylation of sp1 and its subcellular compartmentalization in liver cellsAging leads to increased levels of protein O-linked N-acetylglucosamine in heart, aorta, brain and skeletal muscle in Brown-Norway ratsIncreased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysisAtaxin-10 interacts with O-linked beta-N-acetylglucosamine transferase in the brainNon-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transitionA PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose.O-GlcNAc regulates FoxO activation in response to glucose.O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice.Identification of secret agent as the O-GlcNAc transferase that participates in Plum pox virus infectionO-GlcNAc modifications regulate cell survival and epiboly during zebrafish development.The hexosamine signaling pathway: O-GlcNAc cycling in feast or famineO-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stressO-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs.The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesisRegulation of Dauer formation by O-GlcNAcylation in Caenorhabditis elegans.The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.Toxic effects of hyperglycemia are mediated by the hexosamine signaling pathway and o-linked glycosylation in early mouse embryos.Quantitative secretome and glycome of primary human adipocytes during insulin resistance.
P2860
Q24294511-068CD241-31E1-4429-88A4-DF28D193D4EFQ24299073-638B64BA-E9FE-4701-88C0-5DC9448076E5Q24324116-C9595EFA-8AFA-42C4-8152-B3566A04DA62Q24538581-87B23EE1-67F8-4151-AFFC-ECAFC513A06CQ24627461-3DE91A01-8D6A-4410-B3BC-377249DC8A43Q24648559-6C8AAC89-FEF4-433F-892B-18F7C53806BAQ24670972-5A13C25C-698D-4EF4-9C5F-727A58FF0E14Q26765379-4A848C46-6CB5-4CE9-A034-3B94D1C61787Q27009399-7600C5AE-84AE-4A53-B0DB-25366EE6771AQ27027028-28F8CA2B-14B0-476F-A141-8CF8FBC1F310Q27027815-851EAF0E-1D87-432A-8D7D-260A48CB6E50Q27301833-6A5BD42F-A439-4B4A-9D16-070CE4781ACAQ27650768-56C89156-8866-4580-B5CF-430934BD5A48Q27652457-A334899C-5D66-4367-A72A-ED7C80A73B3BQ27663888-ECF060A5-569F-4A6A-B8A7-7BE7F259D2A5Q27664569-66855A41-981E-4BAF-9ED0-BF10679C34F4Q27666021-5117B1E9-ECAB-4C3E-B48D-6D74DC835582Q27677479-1363591F-FD1B-45DF-A8F4-57B4AF744772Q27677503-57F21EE3-36BC-48E6-929B-F62C92B73EA9Q28284365-BB48AA05-0653-452B-BE01-3D2529BA5A43Q28492135-1ADE06C5-6EE8-474F-876E-E7A2B69F8C6DQ28537913-2DCD58D8-FDCF-4B8C-9E95-4B8F262C79FFQ28566805-FEFC176F-3EC3-4D4C-A08D-039EBC581D83Q28568308-CAA3D052-7C63-462E-8ECB-3FD9B0B776CAQ28568343-9448F024-5B5F-4031-915C-BBAA913981E9Q28572487-636A152E-617D-4A30-8F6D-D0559774FCD1Q28579197-A8917A6D-F60E-410F-9BE6-F6CA9C7A43B9Q30437005-B7EEDC14-61DF-4BB7-B7C9-FFB8C010A76AQ30439420-1C8C9563-769E-4A0B-A185-F6164D2DD51FQ30993051-B9C94207-20B3-4758-A40D-E0575C43CD3AQ33218877-6F1B9AAC-6A6A-4A91-8EBC-F6D7C5F941F1Q33433251-8F8DEEAD-2B72-45C1-900D-B4C3481D0AA3Q33625053-59E3E62E-4AB6-4B74-B5CE-4A32D64B5E5EQ33625265-DB894EFB-831F-4454-91F4-8F3CABD381B7Q33628891-02788584-F631-4DC3-BBE6-D11CE7F56047Q33654365-467D20EA-2F8A-433E-972D-B22A1A31541DQ33661396-8D88A7A8-D92C-4B41-9FB5-A36F934BEC5DQ33683197-3242D956-D6BC-443E-A0F4-4B8F7B871980Q33742336-34CE853C-1650-42F1-89AF-4BC9BAECD88BQ33749585-B5A87C2B-C53C-460D-B5A0-8A62B83D6A6E
P2860
Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Elevated nucleocytoplasmic gly ...... ctivation in 3T3-L1 adipocytes
@ast
Elevated nucleocytoplasmic gly ...... ctivation in 3T3-L1 adipocytes
@en
Elevated nucleocytoplasmic gly ...... ctivation in 3T3-L1 adipocytes
@nl
type
label
Elevated nucleocytoplasmic gly ...... ctivation in 3T3-L1 adipocytes
@ast
Elevated nucleocytoplasmic gly ...... ctivation in 3T3-L1 adipocytes
@en
Elevated nucleocytoplasmic gly ...... ctivation in 3T3-L1 adipocytes
@nl
prefLabel
Elevated nucleocytoplasmic gly ...... ctivation in 3T3-L1 adipocytes
@ast
Elevated nucleocytoplasmic gly ...... ctivation in 3T3-L1 adipocytes
@en
Elevated nucleocytoplasmic gly ...... ctivation in 3T3-L1 adipocytes
@nl
P2093
P2860
P356
P1476
Elevated nucleocytoplasmic gly ...... ctivation in 3T3-L1 adipocytes
@en
P2093
Gerald W Hart
Keith Vosseller
Lance Wells
M Daniel Lane
P2860
P304
P356
10.1073/PNAS.072072399
P407
P577
2002-04-01T00:00:00Z